News

HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention

TUCSON, Ariz., May 18, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools…

2 years ago

iCAD’s ProFound AI Breast Suite Wins U.S. General Services Administration’s AI Healthcare Challenge Award

Company presented portfolio of breast cancer detection, density assessment and risk evaluation solutions at the competition, focused on improving health…

2 years ago

Smart for Life Announces $1.58 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

MIAMI, May 18, 2023 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a…

2 years ago

Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic Cancer

Rucosopasem in clinical development to augment the anti-cancer efficacy of stereotactic body radiation therapyMALVERN, Pa., May 18, 2023 (GLOBE NEWSWIRE)…

2 years ago

Replay Appoints Arun Balakumaran M.D., Ph.D as Chief Medical Officer

Replay Appoints Arun Balakumaran M.D., Ph.D as Chief Medical Officer Arun Balakumaran M.D., Ph.D, appointed Chief Medical Officer of Replay…

2 years ago

Replimune Reports Fiscal Fourth Quarter and Year Ended 2023 Financial Results and Provides Corporate Update

Topline data disclosure from the registration-directed CERPASS clinical trial of RP1 combined with Libtayo® (cemiplimab-rwlc) in cutaneous squamous cell carcinoma…

2 years ago

Science 37 Wins 2023 MedTech Breakthrough Award for “Best Overall Clinical Trial Platform”

Science 37's unified platform that powers the Metasite receives award for outstanding digital health and technology innovationRESEARCH TRIANGLE PARK, N.C., May…

2 years ago

Cognition Therapeutics Publishes Clinical Evidence that CT1812 Displaces Aβ Oligomers from Binding to Neuronal Synapses in Alzheimer’s Disease

- First Human Evidence that CT1812 Selectively Engages Aβ OligomersPURCHASE, N.Y., May 18, 2023 (GLOBE NEWSWIRE) --  Cognition Therapeutics, Inc.…

2 years ago

Standard BioTools Announces NGS Library Preparation as an Upgrade on the X9 High-Throughput Genomics System

Supporting discovery through screening, the X9 is the only system integrating real-time PCR and NGS library preparationSOUTH SAN FRANCISCO, Calif.,…

2 years ago

FibroGen Announces Positive Topline Results from China Pivotal Phase 3 Clinical Trial of Roxadustat for the Treatment of Chemotherapy Induced Anemia

Met primary endpoint of noninferiority of roxadustat to erythropoietin alfaPlan to file supplemental New Drug Application in ChinaSAN FRANCISCO and…

2 years ago